reports
- Cedric Rossi
MISTER SPEX: FY21 guidance revised down as customers have returned to ...
MISTER SPEX - BUY | EUR30 VS. EUR31 (+69%) FY21 guidance revised down as customers have returned to physical stores FY21 sales and aEBITDA outlook revised down Blame the massive and abrupt customer channel shift… … that justifies MRX’s decision to accelerate the pace of store openings TP nudged down to EUR30 to reflect our new forecasts aligned with revised guidance
- Cedric Rossi
MISTER SPEX BUY | EUR31 Focus on H2 sales growth to drive an accelerat...
MISTER SPEX BUY | EUR31 Focus on H2 sales growth to drive an acceleration from 2022 onwards Q2 international sales trends explained On track to reach FY21 sales guidance Reasons for the more prudent margin outlook over FY21 Near-term but equity story is fully intact
- Cedric Rossi
MISTER SPEX: H1 results highlighted Mister Spex’s appealing MT growth ...
MISTER SPEX - BUY | EUR31(+29%) H1 results highlighted Mister Spex’s appealing MT growth story H1 sales a touch above our own expectations Mister Spex largely outperformed its legacy peers in Q2 H1 results: strong GM gains reinvested in opex investments FY21 outlook reiterated
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.